BioSpace News Archive

Blood Test Predicts TNFi Response in Patients Both Naïve to and Experienced with Therapy Providers Can Access Patient-Specific Data for Optimized Therapy Selection.

Optinose, a pharmaceutical company focused on patients treated by ear, nose and throat and allergy specialists, announced Dr. Per Djupesland received the European Inventor Award 2021 in the Industry category from the European Patent Office for his invention of the technology that serves as a basis for the Optinose Exhalation Delivery System.

Aerami Therapeutics, Inc. today announced the initiation of dosing in the Phase 1 clinical trial of its drug-device combination product candidate, AER-901, an inhaled imatinib for the treatment of pulmonary arterial hypertension (PAH).

In many situations, heart muscle cells do not respond to external stresses in the same ways that skeletal muscle cells do.

AbbVie (NYSE: ABBV) and Teneobio, Inc. announced today that AbbVie exercised its exclusive right to acquire TeneoOne, an affiliate of Teneobio, Inc., and TNB-383B, a BCMA-targeting immunotherapeutic for the potential treatment of relapsed or refractory multiple myeloma (R/R MM).

Leonard Award program recognizes innovation and positive achievements in the diabetes community by Eli Lilly and Company.

GT Biopharma, Inc. today announced that GT Biopharma CEO, Tony Cataldo will be presenting as a VIP speaker at the upcoming Sir Anthony Ritossa’s Global Family Office Investment Summit in Monaco from June 30 to July 2, 2021.

Sirnaomics, Inc. announced today dose administration for the first patient in a Phase 1 U.S. clinical study for liver cancer treatment.

ATCC, the world’s premier biological materials management and standards organization, today announced that it’s expanding their collection of next-generation 2-D and 3-D patient tissue-derived in vitro cancer models.

PTC Therapeutics, Inc. (NASDAQ: PTCT) today presented pooled placebo data from multiple studies in which the results confirmed the clinical benefit of EMFLAZA® (deflazacort) over prednisone for the treatment of Duchenne muscular dystrophy (DMD).